These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20010472)

  • 21. Cost savings from peritoneal dialysis therapy time extension using icodextrin.
    Johnson DW; Vincent K; Blizzard S; Rumpsfeld M; Just P
    Adv Perit Dial; 2003; 19():81-5. PubMed ID: 14763039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Home peritoneal ultrafiltration in patients with severe congestive heart failure without end-stage renal disease.
    Bertoli SV; Ciurlino D; Maccario M; Martino S; Bigatti G; Traversi L; Procaccio M; Buzzi L
    Adv Perit Dial; 2005; 21():123-7. PubMed ID: 16686301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of patients with recurrent nephrosis and intractable edema by intraperitoneal instillation of icodextrin solution.
    Morimoto S; Takahashi N; Kikuchi S; Yamahara H; Imada T; Kohno K; Masaki H; Nishikawa M; Iwasaka T
    Perit Dial Int; 2008; 28(5):559-62. PubMed ID: 18708557
    [No Abstract]   [Full Text] [Related]  

  • 24. Long daytime exchange in children on continuous cycling peritoneal dialysis: preservation of drained volume because of icodextrin use.
    Michallat AC; Dheu C; Loichot C; Danner S; Fischbach M
    Adv Perit Dial; 2005; 21():195-9. PubMed ID: 16686317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyponatremia in refractory congestive heart failure patients treated with icodextrin-based peritoneal dialysis: A case series.
    Kunin M; Ganon L; Holtzman EJ; Dinour D
    Nefrologia (Engl Ed); 2018; 38(1):87-91. PubMed ID: 28760437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal dialysis in congestive heart failure.
    Krishnan A; Oreopoulos DG
    Adv Perit Dial; 2007; 23():82-9. PubMed ID: 17886609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration.
    Tormey V; Conlon PJ; Farrell J; Horgan J; Walshe JJ
    QJM; 1996 Sep; 89(9):681-3. PubMed ID: 8917742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with assisted automated peritoneal dialysis using 4.25% glucose dialysate for an elderly patient with refractory heart failure.
    Toda N; Iwaki R; Oishi K; Takasu Y; Komiya T
    CEN Case Rep; 2021 Feb; 10(1):121-125. PubMed ID: 32930999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure.
    Sánchez JE; Ortega T; Rodríguez C; Díaz-Molina B; Martín M; Garcia-Cueto C; Vidau P; Gago E; Ortega F
    Nephrol Dial Transplant; 2010 Feb; 25(2):605-10. PubMed ID: 19783594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
    Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
    Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe cutaneous hypersensitivity to icodextrin in a continuous ambulatory peritoneal dialysis patient.
    Lee SH; Park HC; Sim SR; Chung SJ; Kim KJ; Park WI; Hong SW; Ha SK
    J Nephrol; 2006; 19(5):673-6. PubMed ID: 17136700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation.
    Gotloib L; Fudin R; Yakubovich M; Vienken J
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii32-6. PubMed ID: 16024831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients.
    Moriishi M; Kawanishi H; Tsuchiya S
    Adv Perit Dial; 2006; 22():24-8. PubMed ID: 16983933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.
    Pavo N; Yarragudi R; Puttinger H; Arfsten H; Strunk G; Bojic A; Hülsmann M; Vychytil A
    PLoS One; 2018; 13(11):e0206830. PubMed ID: 30452453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perspectives on treatment of the renal failure].
    Bertolini L; Maggiore U; Savazzi G
    Recenti Prog Med; 2006 Dec; 97(12):759-70. PubMed ID: 17252735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
    Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
    Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a need for low sodium dialysis solution for peritoneal dialysis patients?
    Khandelwal M; Oreopoulos DG
    Adv Perit Dial; 2004; 20():156-62. PubMed ID: 15384818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of refractory congestive cardiac insufficiency by continuous peritoneal dialysis. Long-term course].
    Mousson C; Tanter Y; Chalopin JM; Rebibou JM; Dentan G; Morelon P; Rifle G
    Presse Med; 1988 Sep; 17(32):1617-20. PubMed ID: 2973012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal ultrafiltration and refractory congestive heart failure.
    Ryckelynck JP; Lobbedez T; Valette B; Le Goff C; Mazouz O; Levaltier B; Potier JC; Hurault de Ligny B
    Adv Perit Dial; 1997; 13():93-7. PubMed ID: 9360658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel therapeutic option for refractory heart failure in elderly patients with chronic kidney disease by incremental peritoneal dialysis.
    Nakayama M; Nakano H; Nakayama M
    J Cardiol; 2010 Jan; 55(1):49-54. PubMed ID: 20122548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.